| VEVYX | VVONX | VEVYX / VVONX | |
| Total Expense Ratio | 0.66 | 0.74 | 89% |
| Annual Report Gross Expense Ratio | 0.66 | 0.74 | 89% |
| Fund Existence | 13 years | 15 years | - |
| Gain YTD | -1.266 | 10.938 | -12% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 15.9B | 5.71B | 279% |
| Annual Yield % from dividends | 1.05 | 0.55 | 192% |
| Returns for 1 year | -13.44 | 2.75 | -489% |
| Returns for 3 years | -2.83 | 41.03 | -7% |
| Returns for 5 years | 18.53 | 95.35 | 19% |
| Returns for 10 years | 42.71 | 80.89 | 53% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ETCGX | 50.64 | N/A | N/A |
| Eventide Gilead C | |||
| DFMLX | 36.41 | -0.07 | -0.19% |
| DF Dent Midcap Growth Institutional Plus | |||
| IGFSX | 10.63 | -0.04 | -0.37% |
| VY® Morgan Stanley Global Franchise S2 | |||
| MGIAX | 44.60 | -0.49 | -1.09% |
| MFS International Intrinsic Value A | |||
| GMOIX | 32.42 | -0.46 | -1.40% |
| GMO International Equity III | |||